Saint Anna Children’s Hospital
The St. Anna Children’s Hospital (legal entity: Austrian Red Cross, Vienna branch) has developed from what was once Austria’s first children’s hospital into a large facility that today offers state of the art medical care.
The St. Anna Children’s Hospital has set itself the objective of comprehensively taking into account the psychosocial needs of patients and families in addition to medical treatment.
General information about the clinic
In addition to its function as a general children’s hospital, St. Anna Children’s Hospital is today Austria’s largest, internationally renowned centre for the treatment of childhood blood and tumour diseases (cancer). Since 2010, St. Anna Children’s Hospital has also been a department of the University Hospital for Children and Adolescents and thus part of the Medical University of Vienna.
Management
This “collegial management”, as defined in law, consists of the Medical Director (Medical Director Prof. Dr. Wolfgang Holter, Deputy Senior Physician Dr. Elisabeth Pracher, Senior Physician and Univ. Lecturer Dr. Michael Dworzak), the Head of Nursing (Nursing Director Barbara Hahn, BSc, Deputy Susanne Wieczorek, MSc) and the Head of Administration (Administrative Director Mag. Werner Eibler, MAS). Together with Mag. Alexander Lang (Regional Manager of the Austrian Red Cross, Vienna section), all three persons are also Managing Directors of St. Anna Kinderspital GmbH. The overall objective defines their common tasks: to treat and care for the sick children and adolescents entrusted to St. Anna Children’s Hospital in the best possible, most comprehensive way and to manage the hospital in accordance with the principles of expediency and economic efficiency. This is concurrent with a striving for the well-being of the patients and their accompanying persons, as well as caring for all employees of the hospital.
Capacities
The hospital is equipped with a total of eight wards with 122 systemised beds, including an infant ward, two general paediatric wards, an ear, nose and throat ward, two basic oncology wards, a bone marrow transplant ward and a separate intensive care unit, which is used primarily for monitoring and treating patients following bone marrow transplants and intensive oncology treatments.
There is also a general outpatient clinic for general paediatrics (including an around-the-clock emergency outpatient clinic) as well as eight specialist outpatient clinics for primary care and aftercare. Outpatient clinics and day clinics for oncology, haematology, immunology as well as stem cell transplantation and aftercare have been set up in the haematological-oncological area. State of the art facilities and equipment including CT and MRI in the radiology unit are available for the accurate diagnosis of diseases.
The St. Anna Children’s Hospital performs all treatments of internal diseases in children with the exception of neonatology, as well as operations in the ear, nose and throat area.
The hospital is equipped with a total of eight wards with 122 systemised beds.
Treatment
The St. Anna Children’s Hospital has set itself the objective of comprehensively taking into account the psychosocial needs of patients and families in addition to medical treatment, and works according to an integrative psychosomatic approach. This means that the priority of organ-oriented treatment is maintained and, according to specific circumstances, the psychosocial aspects are also always addressed. This is ensured by a large psychosocial team under the direction of Dr. Reinhard Topf and Deputy Dr. Renate Höfinger). In addition to a team of psychologists, an extensive psychosocial liaison service has been established with various professional groups (social workers, pastoral care, kindergarten teachers, music and art therapy). With longer treatments our patients are supervised and taught by teachers from the Heilstättenschule in Vienna.
Haemato-oncology
In the field of haemato-oncology, patients are currently treated within the framework of approximately 60 different therapy optimisation studies, therapy registers and other clinical studies specialised for the respective disease. These are conducted in close cooperation with St. Anna Children’s Cancer Research Institute, the S²IRP unit (see below) and/or OKIDS according to Good Clinical Practice guidelines and objectives and relevant national/international legislation. An average of 120 children and adolescents with cancer diagnosed for the first time are admitted each year. About 25 patients suffer relapses and approximately 30 patients undergo stem cell transplantation. Each week an average of 10 to 15 patients are discussed and documented in the interdisciplinary tumour board with virtual connection to the other Austrian paediatric oncology centres and in the presence of representatives of specific disciplines, also from units of the AKH.
Psychosocial unit
The psychosocial aspects of the disease are considered by the psychosocial group in close cooperation with the doctors and nursing staff with a holistic view of the patient. This group-oriented liaison service consists of psychologists, kindergarten teachers, after-school care teachers, social workers, music therapists, art therapists, interpreters, the hospital school at St. Anna Children’s Hospital and pastoral care. In oncological-haematological-immunological aftercare, an average of 330 children and families receive follow-up care by the psychology team every year. In general paediatrics, an average of 500 children per year are diagnosed with differential psychology with an average of three contacts.
Mobile care
The Mobile Psychological Service provides ongoing psychological support for families with children and adolescents with cancer, also outside the hospital. The mobile care service is financed by donations from the “Kinderkrebshilfe Wien, Nö und Bgld” (Children’s Cancer Aid for Vienna, Lower Austria and Burgenland).
Management & Contact
© missing
Medical Director
Prof. Dr. Wolfgang Holter
© Private
The OKIDS network headquarters is linked to the site through a collaboration agreement and supports local study activities by providing study nurse capacity.
Study Nurse
Christiana Echtner
© Private
Study Nurse
Angelika Muggi, MSc, BSc
Saint Anna Children’s Hospital
Kinderspitalgasse 6
1090 Wien
Tel.: +43(1)40170-1250
Fax: +43(1)40170-7000
E-Mail: aerztlichedirektionstanna.sign: dotat
Google Map will not be loaded until you click on the button "Load Google Maps". This transfers personal information to Google and sets Cookies. The settings will be saved for 6 months.
St. Anna Children’s Cancer Research Institute
St. Anna Children’s Hospital and the St. Anna Children’s Cancer Research Institute are both part of the European Reference Network for Rare Diseases (ERN) in the field of paediatric haematology and oncology (ERN PaedCan headed by Prof. Dr. Ruth Ladenstein) since 2018. ERN PaedCan is coordinated by Prof. Prof. Dr. Ruth Ladenstein.
For haemato-oncology at St. Anna Children’s Hospital, multimodal interdisciplinary treatment paths are defined by the specialists of St. Anna Children’s Hospital in weekly tumour boards together with the cooperation partners of paediatric surgery, surgery, orthopaedics, radiotherapy, nuclear medicine and pathology of Vienna General Hospital and other hospitals. Together this represents an outstanding system of quality-assured, scientifically documented treatment for the benefit of patients.
S²IRP – “Studies and Statistics for integrated Research and Projects” at St. Anna Children’s Cancer Research Institute
Within the research institute, a Coordination Centre/Centre of Competence for and statistics (S²IRP) was established with a focus on academic haemato-oncological studies. St. Anna Kinderkrebsforschung GmbH has assumed statutory sponsorship responsibility for these academic studies in accordance with EU requirements and the Austrian Medicines Act (AMG) since 2004, and also secured their continued existence with the conclusion of an Austria-wide framework insurance contract with Zurich-Kosmos in September 2005.
To date, the S²IRP has collected and analysed data from more than 9,000 patients with cancer and communicated this in the form of lectures and numerous publications, both nationally and internationally.
In terms of disease patterns, the S²IRP is responsible for international study management in three indication areas:
- Langerhans cell histiocytosis (management of LCH studies I-IV)
- Neuroblastoma (management of the European High Risk Neuroblastoma Study HR-NBL1/SIOPEN
- Stem Cell Transplantation in high risk acute lymphocytic leukaemia (management of the international ALL-SZT study).
The S²IRP provides researchers and industry partners with expertise and support across the full spectrum of legal requirements in planning, organising and conducting clinical studies. The services include consulting, preparation of requisite documents (study protocols, patient information, case report forms), support for database development, execution of approval procedures with ethics committees and authorities as well as fulfilment of various documentation- and reporting obligations, handling of trial medications, planning of monitoring and pharmacovigilance management and project management. All Austrian haemato-oncologists of the Working Group for Haemato-Oncology were trained as investigators and the team of research and study assistants were trained through numerous advanced training courses.
S²IRP Management & Contact
© Private
Head of Unit:
Univ. Prof. Dr. Ruth Ladenstein, MBA, cPM
S²IRP - Studies & Statistics, Integrated Research & Projects
Zimmermannplatz 10
A-1090 Wien
Tel.: +43 (0)1 40470 0
Fax: +43 (0)1 40470 7150
Google Map will not be loaded until you click on the button "Load Google Maps". This transfers personal information to Google and sets Cookies. The settings will be saved for 6 months.